- Home
- SPCB vs IXHL Comparison
SPCB vs IXHL Comparison
Compare SPCB & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- IXHL
- Stock Information
- Founded
- SPCB 1988
- IXHL 2001
- Country
- SPCB Israel
- IXHL Australia
- Employees
- SPCB N/A
- IXHL N/A
- Industry
- SPCB Semiconductors
- IXHL
- Sector
- SPCB Technology
- IXHL
- Exchange
- SPCB Nasdaq
- IXHL Nasdaq
- Market Cap
- SPCB 48.3M
- IXHL 49.1M
- IPO Year
- SPCB N/A
- IXHL N/A
- Fundamental
- Price
- SPCB $10.24
- IXHL $0.35
- Analyst Decision
- SPCB Strong Buy
- IXHL
- Analyst Count
- SPCB 1
- IXHL 0
- Target Price
- SPCB $18.00
- IXHL N/A
- AVG Volume (30 Days)
- SPCB 112.7K
- IXHL 34.3M
- Earning Date
- SPCB 11-13-2025
- IXHL 11-13-2025
- Dividend Yield
- SPCB N/A
- IXHL N/A
- EPS Growth
- SPCB N/A
- IXHL N/A
- EPS
- SPCB 0.98
- IXHL N/A
- Revenue
- SPCB $27,426,000.00
- IXHL $86,000.00
- Revenue This Year
- SPCB N/A
- IXHL $1,188.37
- Revenue Next Year
- SPCB $29.31
- IXHL N/A
- P/E Ratio
- SPCB $10.83
- IXHL N/A
- Revenue Growth
- SPCB 2.17
- IXHL 616.67
- 52 Week Low
- SPCB $2.97
- IXHL $0.08
- 52 Week High
- SPCB $18.95
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- SPCB 43.47
- IXHL 35.00
- Support Level
- SPCB $9.71
- IXHL $0.37
- Resistance Level
- SPCB $11.28
- IXHL $0.50
- Average True Range (ATR)
- SPCB 0.67
- IXHL 0.04
- MACD
- SPCB -0.21
- IXHL -0.01
- Stochastic Oscillator
- SPCB 18.70
- IXHL 4.19
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.